CMO, Hematology of Beigene, Ltd. (NASDAQ:BGNE), Huang Jane, sells 1,935 shares worth $369,250

According to Beigene, Ltd.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jun 30 04:14 PM, company CMO, Hematology, Huang Jane disclosed selling 1,935 shares at a cost of $190.83. At the time of this transaction (Jun 29), this trade was worth $369,250 in total. As of Jun 29, Huang Jane now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Beigene, Ltd. (NASDAQ:BGNE) CMO, Hematology, Huang Jane, we have the following information:

  1. SEC Form 4 filing: Jun 26: Sold 2,079 shares at the rate of $200.29 per share. Total worth of this trade was $416,397. Total number of shares owned as of Jun 26 were 0
  2. SEC Form 4 filing: Jun 08: Sold 631 shares at the rate of $170.84 per share. Total worth of this trade was $107,800. Total number of shares owned as of Jun 08 were 0
  3. SEC Form 4 filing: May 29: Sold 1,500 shares at the rate of $163.86 per share. Total worth of this trade was $245,784. Total number of shares owned as of May 29 were 0
Posted by on Tuesday June 30 2020, 5:28 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in